Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Echo Therapeutics, Inc. | w76346qe10vq.htm |
| EX-31.2 - EX-31.2 - Echo Therapeutics, Inc. | w76346qexv31w2.htm |
| EX-31.1 - EX-31.1 - Echo Therapeutics, Inc. | w76346qexv31w1.htm |
| EX-32.2 - EX-32.2 - Echo Therapeutics, Inc. | w76346qexv32w2.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Echo Therapeutics, Inc. (the “Company”) for
the period ended September 30, 2009 as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Patrick T. Mooney, M.D., Chief Executive Officer and Chairman of the
Board of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the
Sarbanes-Oxley Act of 2002:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
| /s/ Patrick T. Mooney, M.D. | ||||
| Patrick T. Mooney, M.D. | ||||
| Chief Executive Officer and Chairman of the Board |
||||
November 19, 2009
35